Weinstein MC - Search Results

1

Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.

Yazdanpanah Y, Losina E, Anglaret X, Goldie SJ, Walensky RP, Weinstein MC, Toure S, Smith HE, Kaplan JE, Freedberg KA; Global AIDS Policy Model Investigators. Yazdanpanah Y, et al. Among authors: weinstein mc. AIDS. 2005 Aug 12;19(12):1299-308. doi: 10.1097/01.aids.0000180101.80888.c6. AIDS. 2005. PMID: 16052085 Clinical Trial.

2

Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS.

Schackman BR, Goldie SJ, Freedberg KA, Losina E, Brazier J, Weinstein MC. Schackman BR, et al. Among authors: weinstein mc. Med Decis Making. 2002 Jan-Feb;22(1):27-38. doi: 10.1177/0272989X0202200103. Med Decis Making. 2002. PMID: 11833663

3

Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.

Goldie SJ, Kaplan JE, Losina E, Weinstein MC, Paltiel AD, Seage GR 3rd, Craven DE, Kimmel AD, Zhang H, Cohen CJ, Freedberg KA. Goldie SJ, et al. Among authors: weinstein mc. Arch Intern Med. 2002 Apr 22;162(8):921-8. doi: 10.1001/archinte.162.8.921. Arch Intern Med. 2002. PMID: 11966344

4

Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy.

Walensky RP, Goldie SJ, Sax PE, Weinstein MC, Paltiel AD, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, Islam R, Freedberg KA. Walensky RP, et al. Among authors: weinstein mc. J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):27-37. doi: 10.1097/00126334-200209010-00004. J Acquir Immune Defic Syndr. 2002. PMID: 12352147

5

Empirically calibrated model of hepatitis C virus infection in the United States.

Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Salomon JA, et al. Among authors: weinstein mc. Am J Epidemiol. 2002 Oct 15;156(8):761-73. doi: 10.1093/aje/kwf100. Am J Epidemiol. 2002. PMID: 12370165

6

Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults.

Schackman BR, Freedberg KA, Weinstein MC, Sax PE, Losina E, Zhang H, Goldie SJ. Schackman BR, et al. Among authors: weinstein mc. Arch Intern Med. 2002 Nov 25;162(21):2478-86. doi: 10.1001/archinte.162.21.2478. Arch Intern Med. 2002. PMID: 12437408

7

Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy.

Yazdanpanah Y, Goldie SJ, Losina E, Weinstein MC, Lebrun T, Paltiel AD, Seage GR 3rd, Leblanc G, Ajana F, Kimmel AD, Zhang H, Salamon R, Mouton Y, Freedberg KA. Yazdanpanah Y, et al. Among authors: weinstein mc. Antivir Ther. 2002 Dec;7(4):257-66. Antivir Ther. 2002. PMID: 12553480

8

Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.

Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Salomon JA, et al. Among authors: weinstein mc. JAMA. 2003 Jul 9;290(2):228-37. doi: 10.1001/jama.290.2.228. JAMA. 2003. PMID: 12851278

9

Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection.

Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR 3rd, Kimmel AD, Walensky RP, Sax PE, Freedberg KA. Goldie SJ, et al. Among authors: weinstein mc. Am J Med. 2003 Dec 1;115(8):632-41. doi: 10.1016/j.amjmed.2003.07.007. Am J Med. 2003. PMID: 14656616

10

Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.

Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, Franco E. Goldie SJ, et al. Among authors: weinstein mc. J Natl Cancer Inst. 2004 Apr 21;96(8):604-15. doi: 10.1093/jnci/djh104. J Natl Cancer Inst. 2004. PMID: 15100338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

374 results

Search Page